Both in Biotechnology
Inhibrx Biosciences vs Odyssey Therapeutics
Over the past year INBX returned −20.6% and ODTX returned −20.8%; their daily moves had a correlation of 0.31.
INBX −20.6% ODTX −20.8%Growth of $1, one year, split-adjusted
| Metric | INBX | ODTX |
|---|---|---|
| Price | $86.76 | $19.50 |
| Market cap | $1.28B | $937.1M |
| Today | +7.01% | −9.60% |
| 1 month | −7.1% | +7.6% |
| 6 months | −38.8% | — |
| Year to date | +9.8% | — |
| 1 year | +6.5% | — |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | -$42.9M | $310.6M |
| Dividend yield | — | — |
| Volatility (60d) | 88.8% | — |
| Short % of float | 35.5% | 13.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).